UCLA researchers invented a potential COVID-19 treatment that uses nanotechnology and enzymes to reduce lung inflammation. Yunfeng Lu, a chemical and biomolecular engineering professor, said his team found that the naturally occurring enzyme called catalase could reduce the severity of COVID-19. Read more...
Science & Health
Campus, News, Science & Health
|
October 27, 5:15 pm
UCLA implements weekly COVID-19 testing for people who attend class, work on campus
This post was updated Nov. 1 at 7:50 p.m. UCLA requires students, faculty and staff on campus to receive weekly COVID-19 tests starting Monday. People who visit campus at least once a week, except for those who work for UCLA Health, will have to schedule weekly COVID-19 tests, according to an Oct. Read more...
Photo: Students, faculty and staff who visit campus at least once a week need to take regular compulsory COVID-19 tests. Other members of the UCLA community are recommended to test often, and UCLA will start a mobile testing service to facilitate community testing. (Justin Jung/Daily Bruin senior staff)
California, News, Science & Health
|
October 26, 4:53 pm
Proposition 14 would borrow up to $5.5B in bonds to fund stem cell research
California voters will decide whether the state should increase funding for stem cell research in the 2020 elections. Proposition 14 is a California ballot measure on the 2020 general election ballot that would allocate $5.5 billion in state bonds to stem cell research and training with repayments by the state to buyers of the bonds over the next 30 years. Read more...
Photo: Proposition 14 is a ballot measure that, if passed, would assign money through the sale of state bonds for stem cell research. Stem cell research is used to develop regenerative medicine. (Amy Dixon/Daily Bruin senior staff)
International, News, Science & Health
|
October 22, 7:48 pm
New study explores how tracking virus mutations affects understanding of COVID-19
Tracking mutations in the virus that causes COVID-19 may help find a vaccine and could explain reductions in the COVID-19 death rate, a UCLA researcher said. Read more...
Photo: (Illustration by Shruti Iyer/Daily Bruin senior staff)
California, National, News, Science & Health, UC
|
October 21, 3:57 pm
UC researchers named to new state advisory group overseeing vaccine development
UCLA and University of California researchers will lead a team that will advise California officials on a COVID-19 vaccine distribution plan. California Gov. Gavin Newsom named a Scientific Safety Review Workgroup in a press release Monday, which will help California government officials vet a COVID-19 vaccine when it is available and help officials develop a plan to distribute the vaccine. Read more...
Photo: Gov. Gavin Newsom assembled a team of researchers and medical experts to advise California officials on the creation and distribution of a COVID-19 vaccine. (Justin Jung/Daily Bruin senior staff)
Campus, News, Science & Health
|
October 19, 7:19 pm
UCLA health panel talks importance of communities of color in vaccine research
The development of a successful vaccine for COVID-19 depends on public trust and participation from underserved communities in vaccine trials, a panel of UCLA health professionals said. Read more...
Photo: The success of a COVID-19 vaccine will depend on the trust and participation of underrepresented communities. However, mistrust of research institutes is a barrier between communities and their participation in vaccine trials. (Photo by Noah Danesh)
Campus, National, News, Science & Health
|
October 15, 4:53 pm
UCLA researchers’ more efficient, less expensive COVID-19 test authorized by FDA
UCLA received an emergency authorization from the Food and Drug Administration last week to conduct a fast and cheap COVID-19 test. The new test, called SwabSeq, can return results in 12 to 24 hours, said Sri Kosuri, an associate chemistry and biochemistry professor who helped develop the technology. Read more...
Photo: SwabSeq is a new COVID-19 test developed by UCLA researchers. The test is cheaper, produces results faster and removes many logistical challenges for mass testing. (Courtesy of Octant)